Digest Network Come funziona
Network
/
Società
Ar
Non verificato

Arima Genomics, Inc.

Di cosa scriviamo

BiotecnologiaMedicina - VarieOncologiaSaluteScienza

12 comunicati stampa

Guarda tutti i comunicati
16/06/2026
Eventi
Industria
Biotecnologia
Salute
Oncologia
Arima Genomics Named to Fast Company’s 2026 World Changing Ideas List for Aventa Lymphoma Test
Fonte
Arima Genomics, Inc.
Emittente
Business Wire
1.00
0
11/06/2026
Eventi
Oncologia
Salute
Biotecnologia
Scienza
Arima Genomics to Present Data at AMP Europe Showing Hi-C Sequencing Outperforms High-Coverage Whole Genome Sequencing for Lymphoma Rearrangement Detection
Fonte
Arima Genomics, Inc.
Emittente
Business Wire
1.00
0
15/04/2026
Eventi
Oncologia
Salute
Biotecnologia
Scienza
Arima Genomics Announces AACR 2026 Presentations Across Solid Tumors
Fonte
Arima Genomics, Inc.
Emittente
Business Wire
1.00
0
26/02/2026
Industria
Scienza
Biotecnologia
Medicina - Varie
Salute
Farmaceutica
Sanità
Oncologia
Arima Genomics Announces Publication of New Study Supporting the Whole-Genome Rearrangement Detection Approach Behind Aventa Lymphoma
Fonte
Arima Genomics, Inc.
Emittente
Business Wire
1.00
0
04/12/2025
Eventi
Fiere
Scienza
Medicina - Varie
Associazioni/Professionisti
Biotecnologia
Salute
Oncologia
Arima Genomics Reports New Data at ASH 2025 Supporting More Complete Rearrangement Profiling in DLBCL With Hi-C Technology Used in Aventa Lymphoma
Fonte
Arima Genomics, Inc.
Emittente
Business Wire
1.00
0
13/11/2025
Scienza
Biotecnologia
Oncologia
Salute
Medicina - Varie
Sanità
Eventi
Industria
Arima Genomics Announces Data Presentation at the Association for Molecular Pathology 2025
Fonte
Arima Genomics, Inc.
Emittente
Business Wire
1.00
0
06/11/2025
Eventi
Industria
Oncologia
Salute
Biotecnologia
Medicina - Varie
Scienza
Arima Genomics Wins BioTech Breakthrough Award For “Clinical Diagnostics Solution of the Year”
Fonte
Arima Genomics, Inc.
Emittente
Business Wire
1.00
0
15/10/2025
Attrezzature medico-sanitarie
Salute
Biotecnologia
Medicina - Varie
Oncologia
Industria
Arima Genomics Announces New Study Showing Aventa™ Lymphoma Test Resolves Diagnostic Ambiguity and Guides Care in B-Cell Lymphoma Cases
Fonte
Arima Genomics, Inc.
Emittente
Business Wire
1.00
0
03/09/2025
Biotecnologia
Salute
Oncologia
Attrezzature medico-sanitarie
Industria
Arima Genomics Introduces Aventa Lymphoma Test to Resolve Diagnostic Uncertainty in B- and T-Cell Lymphomas
Fonte
Arima Genomics, Inc.
Emittente
Business Wire
1.00
0
17/06/2025
Arima Genomics Appoints Genomics Industry Veteran Tom Willis as Chief Executive Officer and Closes $22 Million Series C Financing
Fonte
Arima Genomics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0